Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal ECMO Flow in the Critical Phase of Cardiogenic Shock to Optimize Peripheral Organ Perfusion and Myocardial Stress

NCT06936839 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT06936839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06936839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal ECMO Flow in the Critical Phase of Cardiogenic Shock to Optimize Peripheral Organ Perfusion and Myocardial Stress
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Not yet recruiting
Start date
April 15, 2025
Completion date
April 1, 2026
Enrollment
55 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiogenic shock